Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you. Thanks!

Editorial disclosure. Some providers in this audit have paid affiliate relationships with weightlossproviderguide.com elsewhere on the site. Affiliate payouts do not control this audit's findings, ordering, or scoring. Every provider is held to the same standardized rubric using publicly verifiable data. Full disclosure list at the bottom of the page.

Research · Passive Backlink Asset · CC BY 4.0

True Cost of GLP-1 Telehealth: 2026 First-Year Cost Audit

By WPG Research Team·Phase 1 — Public-Source Pricing Audit··Data version: v1.0·Providers audited: 30

Every cell is dated and sourced. Rows where we've completed full checkout testing with timestamped screenshots are marked ✓ Checkout-verified. Rows still pending checkout testing are marked Public-source estimate with a stated assumption set. We never collapse the two.

Bottom Line Up Front

The true cost of GLP-1 telehealth is almost never the price on the homepage. The "$99/month" or "starting at $149" you see is usually one of three things: a first-month promo, a starter-dose price you'll only pay for the first 4–8 weeks, or a care membership that doesn't include the medication itself. That's not always a hidden cost — sometimes it's clearly disclosed — but it's almost always more than the headline number suggests once you reach your maintenance dose.

This audit compares 30 providers on a standardized formula: mandatory membership + medication at maintenance dose × 12 months + required labs + required visits + required shipping + unavoidable commitment or cancellation costs. Each cost component is audited, labeled, and dated separately.

Quick Stats from the Audit (Phase 1, May 8, 2026)

30

GLP-1 telehealth providers compared on identical fee schema

22 of 30

rows classified as medication not included in the advertised price

18 of 30

rows classified as recurring membership or care-access fee required

11 of 30

rows use first-month, starter-dose, or limited-time pricing in the headline number

9 of 30

rows with separate, state-specific, or refill-only lab handling

7 of 30

rows with annual or multi-month commitment in public terms

Cheapest Phase 1 public-source starting price: CoreAge RX advertises compounded semaglutide from $99/month and compounded tirzepatide from $149/month, all doses same price, no membership fee, when paid annually. Phase 2 checkout verification pending.

What Is the True Cost of GLP-1 Telehealth in 2026?

The true cost of GLP-1 telehealth is the total required first-year cash cost at your maintenance dose — not the first-month promo price. It includes the membership or care fee, the medication at the dose you'll actually be on by month 4–6, required labs, required visits, shipping, and any unavoidable cancellation or commitment costs.

The standardized formula we use

True first-year cost = mandatory membership + medication at maintenance dose × 12 months + required labs + required visits + required shipping/supplies + unavoidable commitment or cancellation costs.

Why we use maintenance dose, not starter dose

Most patients reach their maintenance dose around month 4 to 6. For Wegovy, the labeled maintenance dose is 2.4 mg once weekly. For Zepbound, the labeled maintenance doses for chronic weight management include 5 mg, 10 mg, and 15 mg once weekly (the labeled starting dose of 2.5 mg is not a maintenance dose). A "$99/month" headline that only reflects the 2.5 mg starter dose understates year-one cost by $3,000+ in some brand-name paths.

What we actually verified for v1.0:

  • Advertised price language on each provider's pricing or terms page on May 8, 2026.
  • Membership fee structure as published on each provider's pricing or terms page.
  • Whether the medication is included in the advertised price as published.
  • Cancellation, commitment, and refund language as published on each provider's terms page.
  • Lab handling language as published on each provider's pricing, FAQ, or terms page.
  • Manufacturer cash-pay pricing for Wegovy (Novo Nordisk) and Zepbound and Foundayo (Eli Lilly) as published on official pages.
  • The FTC's July 2025 NextMed enforcement action and the FDA's February 20, 2026 warning letter #721455 to MEDVi as published in primary sources.
  • Phase 2 checkout verification (timestamped screenshots from intake to payment screen) is still in progress. Status is visible per row.

GLP-1 Telehealth Fee Comparison: 30 Providers

Cells marked [NEEDS CHECKOUT VERIFICATION] show the public-source estimate while Phase 2 audit is still in progress. Status is visible per row. Last full review: .

#ProviderMedication pathAdvertised "from" priceMandatory membershipMed. included?Lab feesDose-escalation upchargeCancellation / commitmentPublic-source first-year estimateStatus
1Ro BodyBrand-name + compounded$39 first month, $149/mo monthly membership; annual optionYes✗ NoLab kit may applyBrand follows manufacturer; compounded variesMonth-to-month or annual; commitment terms in checkoutCare fee year-one: ~$1,678 (monthly path) before medication. Medication path math [NEEDS CHECKOUT VERIFICATION]Public-source
2Hims Weight LossBrand + compounded sema/tirz$39 first month, $149/mo membership thereafterYes✗ NoPer company termsBrand follows Novo/Lilly cash-pay; compounded variesMonth-to-month per public termsCare fee year-one: $1,678 before medication. Medication path math [NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION]Public-source
3Hers Weight LossBrand + compounded sema/tirzMirrors Hims structureYes✗ NoPer company termsBrand follows manufacturerMonth-to-month per public termsCare fee year-one: ~$1,678 before medication [NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION]Public-source
4WeightWatchers Med+Brand-name (Wegovy, Zepbound, Wegovy pill)$25 first month with 12-month commitment, $74/mo afterYes (12-mo commit)✗ NoNot bundledBrand follows manufacturer cash-pay tiers12-month commitment at the discounted priceCare fee year-one: $25 + $74 × 11 = $839 before medication. Medication adds $3,000–$10,000+ depending on pathPublic-source
5GoodRx CareBrand-name (Wegovy, Ozempic, Zepbound)$39/month online care + medicationYes ($39/mo care)✗ NoN/A for care feeWegovy injection: $199/mo first 2 fills (0.25/0.5 mg only), $349/mo subsequent fills, $399/mo Wegovy HD 7.2 mg per Novo offer through June 30, 2026Month-to-month per public termsCare year-one: $468 + Wegovy ~$3,888 (with offer) = ~$4,356 all-in for the Wegovy injection pathPublic-source
6Walgreens Weight MgmtBrand: Wegovy pill, Wegovy injection, Zepbound KwikPen, Foundayo pill$49 initial video visit, $49 follow-ups when requiredNone (visit-based)✗ NoNot required for first visit; required for refillsWegovy pill: $149/mo for 1.5/4 mg through Aug 31, 2026; $299/mo higher doses; Wegovy injection: $199/mo first 2 fills then $349/mo per Novo offerNo subscription; per-visit modelMedication-only varies by path; visit cost depends on follow-up cadence (not annualized without verified schedule)Public-source
7Sesame (Success by Sesame)Brand (Wegovy injection, Wegovy pill, Zepbound, Foundayo)$99/mo monthly OR $59/mo on annual planYes✗ NoIncluded in subscription except in some states where additionalBrand follows manufacturer; Novo offer for Wegovy injectionAnnual plan = annual billing cadenceAnnual plan year-one: $708 care + Wegovy injection ~$3,888 = ~$4,596 all-inPublic-source
8Mochi HealthCompounded sema, compounded tirz; insurance integration available$79/mo membership + medicationYes ($79/mo)✓ YesLab review where appropriateCompounded sema $99/mo, compounded tirz $199/mo per public pricingMonth-to-month per public termsSema path: ($79+$99)×12 = $2,136. Tirz path: ($79+$199)×12 = $3,336Public-source
9MEDViCompounded sema, compounded tirz, oral GLP-1; brand at premiumCompounded sema $179 first month, $299/mo refills; compounded tirz $349/mo; oral $249/moNone additional advertised✓ YesOrdered if medically necessary via QuestPer published reporting on MEDVi termsAuto-renew; cancellation must occur at least 72 hours before next billing dateSema path: $179 + $299×11 = $3,468. Tirz path: $349×12 = $4,188. ⚠ Feb 20 2026 FDA warning letter #721455 (misbranding)Public-source
10GobyMedsCompounded sema 12-week plans; compounded tirz 12-week plans; brand at higher costCompounded sema 12-week Starter Plan $299; higher-dose from $399 (0.2–1.5 mg) or $499 (1.9–2.3 mg). Compounded tirz from $399, higher-dose $499–$599None advertised✓ YesNone advertised; LegitScript-certified per public claimTiered by dose — clearly disclosedPer public termsMaintenance-dose first-year cost requires checkout verification and stated dose-schedule assumption — flaggedPublic-source
11CoreAge RXCompounded sema $99/mo, compounded tirz $149/mo when paid annuallyPer public claimNone advertised✓ YesNone advertised"All doses same price" per published FAQ; "price locks at checkout regardless of dose increases"Per public claim, no cancellation feesSema annual: $99×12 = $1,188. Tirz annual: $149×12 = $1,788. [NEEDS CHECKOUT VERIFICATION of annual billing, state availability]Public-source
12MyStart HealthCompounded sema, compounded tirz$149/mo on the 3-month compounded sema plan with price-lock guarantee per public claimNone advertised✓ YesNone advertisedPrice-lock claim per public statementMulti-month plansSema path with price-lock: $149×12 = $1,788 [NEEDS CHECKOUT VERIFICATION]Public-source
13OnlineSemaglutide.org / CareGLPCompounded sema; brand availability per FAQVariable + $80 telehealth consult fee in fine print if no order proceeds (third-party documented)None advertised✓ YesPer public claimPer public claimPer-fillFirst-year math [NEEDS CHECKOUT VERIFICATION] — the headline issue is the fine-print $80 fee, not the per-month pricePublic-source
14EdenCompounded sema, compounded tirz; brand at higher costFlat-rate plan per public claim; $80-off first-month promo widely advertisedPer public pages✓ YesNone advertisedFlat-rate per public claimMonth-to-month per public claimFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
15Henry MedsCompounded sema, compounded tirzMonthly and multi-month plansPlan-based✓ YesNone advertisedPer plan, not dose-based per public claimCancellation via portal/email/phone; on multi-month plans, remaining balance owed if cancelling early unless medically unable to continue; refunds limited to medically ineligible casesFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
16Noom Med — branded pathBrand-name medication path$69 first month + $99/mo thereafter; medication separateYes ($99/mo)✗ NoPer programBrand follows manufacturerMonth-to-monthCare year-one: $69 + $99×11 = $1,158 before medication. Medication adds path-dependent costPublic-source
17Noom Med — GLP-1 program pathBundled compounded pathAll-inclusive program pricing per public pages (multiple plan tiers)Yes (program-based)✓ YesPer programPer planPer-plan termsFirst-year math [NEEDS CHECKOUT VERIFICATION] — multiple plan tiers; do not collapse with branded pathPublic-source
18CalibrateInsurance-favored model, brand and compounded pathsVariable program fee per public materialsYes (program fee)Sometimes (insurance-dependent)Labs typically requiredInsurance-dependentRefund limits, notice windows in public termsFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
19PlushCareBrand-name primarily; insurance-friendlyMembership + per-visit feesYes✗ NoPatient paysInsurance-dependentMonth-to-month per public termsFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
20FoundCompounded + brandMonthly CORE $129/30 days; Quarterly CORE 2× $348 for 6-month commitment; 6-Month CORE $594YesNo on brand pathPer programPer programSubscription fees final / non-refundable to extent permitted by law per published offer terms; cancel in app/portal, retain access through end of billing periodYear-one (Monthly CORE care fee only): $129×12 = $1,548 before medication. Medication path math [NEEDS CHECKOUT VERIFICATION]Public-source
21LifeMDBrand-name + compoundedSubscription + medicationYesNo on brand pathPer programBrand follows manufacturerMonth-to-month per public pagesFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
22Amazon One MedicalBrand via Amazon Pharmacy: Wegovy injection, Wegovy pill, Zepbound KwikPen and auto-injector, Foundayo pillNo One Medical membership required to start GLP-1 Management Program. Wegovy injection cash-pay starts at $299/mo; Wegovy pill $149/mo; Zepbound KwikPen starts at $299/mo; Foundayo $149/mo or $25/mo with eligible commercial insuranceNone required to startNo — medication separateInsurance-dependentBrand follows manufacturer cash-pay tiersPer public termsMedication-only year-one varies by path; no automatic membership addPublic-source
23Lemonaid HealthCompounded sema, compounded tirz, microdose paths; brand via LillyDirect for Zepbound vials$49/mo membership + medication: compounded sema $299/mo monthly, $249/mo on 3-month plan; compounded tirz $299/mo monthly, $249/mo on 3-month, $229/mo on 6-month; microdose paths $199/mo monthly; Ozempic $1,199/mo, Wegovy $1,599/mo billed separatelyYes ($49/mo)✗ NoPer program; cash-pay onlyDose changes don't add fees on same medication per public claimMonth-to-month per public terms; cash-pay only; HSA/FSA acceptedMicrodose path: $588 + $2,388 = $2,976. Standard compounded monthly: $588 + $3,588 = $4,176 before multi-month discountPublic-source
24Join FridaysCompounded GLP-1 + insurance assistance for brandSema from $117/mo, tirz as low as $198/mo per current public pricing; membership includedYes (bundled)✓ YesQuest lab tests fully included in monthly subscription per public claimPer programPer-plan termsYear-one estimate (sema): ~$1,404+; (tirz): ~$2,376+ [NEEDS CHECKOUT VERIFICATION for promo codes, term, recurring billing]Public-source
25IVIM HealthCompounded GLP-1Subscription per public pagesPer public pages✓ YesPer programPer programPer public termsFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
26ReflexMDCompounded sema, compounded tirzPer-month subscriptionPer public pages✓ YesPer programPer public claimPer public termsFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
27OrderlyMedsCompounded GLP-1Per-month / per-fillNone advertised✓ YesPer programPer public claimMonth-to-month per public claimFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
28ShedRx (SHED)Compounded + brand optionsSubscription + medicationYesBundled per most plansPer programPer programPer public termsFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
29FuturHealthCompounded + brandSubscription + medicationYesPer planPer programPer public claimPer public termsFirst-year math [NEEDS CHECKOUT VERIFICATION]Public-source
30Form HealthInsurance-billed brand-name modelProgram fee structure dependent on insuranceYes (program fee)Sometimes (insurance)Often requiredBrand follows manufacturerPer public termsFirst-year math [NEEDS CHECKOUT VERIFICATION — heavily insurance-dependent]Public-source

⚠ MEDVi regulatory note

On February 20, 2026, the FDA issued warning letter #721455 to MEDVi LLC, citing misbranding under FDCA sections 502(a) and 502(bb) for false or misleading marketing — including claims such as "Same active ingredient as Wegovy® and Ozempic®" and "Same active ingredient as Mounjaro® and Zepbound®" that the FDA determined imply FDA approval or evaluation of compounded products. The letter is not a finding that any specific shipped medication injured patients, but it is more than a minor labeling issue. In March 2026, the FDA issued similar warning letters to 30+ other telehealth companies marketing compounded GLP-1s. Source: FDA Warning Letter #721455 to MEDVi, LLC, 02/20/2026.

Definitions used in the table

Compounded GLP-1 = a non-FDA-approved compounded drug product dispensed by a state-licensed pharmacy or produced by an outsourcing facility when applicable legal conditions are met. It is not a generic version of Wegovy, Ozempic, Zepbound, Mounjaro, or Foundayo, and the FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.

Maintenance dose = the long-term dose a patient is intended to stay on after titration (Wegovy: 2.4 mg weekly; Zepbound: 5 mg, 10 mg, or 15 mg weekly; compounded equivalents vary by program).

Mandatory membership = a recurring care-access or platform fee required for treatment, separate from the medication cost.

How We Calculate True First-Year Cost at Maintenance Dose

What we include

  • Mandatory membership (recurring care-access or platform fee)
  • Medication at maintenance dose × 12 months (titration months modeled separately)
  • Required labs per provider terms
  • Required visits (not annualized unless cadence is verified)
  • Required shipping or supplies
  • Unavoidable commitment or cancellation costs

What we exclude from the main number

  • Insurance estimates (deductibles, networks, prior auths vary)
  • Manufacturer coupons and savings programs (expire, change eligibility)
  • Introductory first-month discounts
  • Voluntary coaching add-ons and at-home lab kits
  • Non-required accessories
  • Taxes unless visible in displayed checkout total
  • Costs after year one

A Worked Example — Transparent Math

Lemonaid Health — standard compounded semaglutide monthly

  • Membership: $49/mo × 12 = $588 year one
  • Compounded sema: $299/mo × 12 = $3,588 year one (drops to $249/mo on 3-month plan)
  • Labs: per program; verify state
  • Total cash year-one (standard monthly path): ~$4,176 before any multi-month discount

CoreAge RX — compounded sema annual (per public claim, pending checkout verification)

  • No membership
  • $99/mo × 12 = $1,188 year one (annual billing claim, all-doses-same-price claim)
  • Public-source gap vs. Lemonaid: ~$2,988 — exactly why this audit exists

What We Classify as a Hidden Fee (The Fairness Rules)

Not every separate fee is a "hidden fee." A charge can be high without being hidden. We use a five-label classification so the audit stays honest.

LabelWhat it meansExample
HiddenRequired, but not clearly disclosed near the advertised price or before a material commitment.A telehealth consultation fee that only appears in the checkout fine print after entering payment information.
Separate but disclosedRequired, but clearly disclosed. The price page or FAQ tells you up front."Membership required; medication billed separately" stated on the homepage.
ConditionalDepends on state, dose, medication, insurance, labs, or eligibility.Lab fees added in some states but not others.
OptionalNot required to continue treatment.Premium coaching add-on.
UnverifiedCould not be confirmed without medical misrepresentation, an inappropriate payment step, or a state we couldn't test.Insurance copay estimate where eligibility wasn't established.
Our editorial rule on compounded products: We do not treat compounded GLP-1 products as generic versions of FDA-approved drugs, and we do not repeat provider claims that imply FDA approval, sameness, or equivalent safety/effectiveness unless the claim is being documented as a claim made by the provider. This rule exists because the FDA's February 2026 warning letter to MEDVi specifically cited "Same active ingredient as Wegovy®" and similar language as misbranding.

Which GLP-1 Telehealth Providers Have Hidden Fees or Separate Required Costs?

Across 30 GLP-1 telehealth providers as of May 8, 2026, the most common required-but-not-hidden costs are recurring memberships, separately billed medication, and refill-only or state-specific lab fees. The clearest hidden fee documented in the public record is OnlineSemaglutide.org's $80 telehealth consultation fee surfaced in checkout fine print when no order is placed, identified by Policy Lab during third-party checkout testing.
ProviderMost relevant feeClassificationSource type
OnlineSemaglutide.org / CareGLP$80 telehealth consult fee in fine print if no order proceedsHidden per third-party checkout test (Policy Lab)Third-party verification
Hims, Ro Body, Hers, GoodRx Care, WW Med+, Sesame, Walgreens, Lemonaid, Noom (branded), Mochi, Amazon One MedicalMedication billed separately from membership/care feeSeparate but disclosedPublic-source
WeightWatchers Med+12-month commitment to access $25/$74 pricingSeparate but disclosedPublic-source
SesameLab fees in some statesConditionalPublic-source
WalgreensLabs required for refills, not first prescriptionConditionalPublic-source
Henry MedsMulti-month balance owed if cancelling early unless medically unable; refunds limited to medically ineligible casesSeparate but disclosedPublic-source
FoundSubscription fees final / non-refundable to extent permitted by lawSeparate but disclosedPublic-source
MEDViAuto-renew with 72-hour cancellation window before next billingSeparate but disclosedPublic-source
GobyMedsDose-tiered 12-week plan pricing (higher doses cost more)Separate but disclosedPublic-source

Categories per provider get upgraded to Hidden only when checkout testing surfaces an undisclosed required charge.

The 5 Fee Categories That Drive the Advertised-to-Actual Gap

1. Medication Billed Separately from Membership

22 of 30 providers in this audit use this structure as of May 8, 2026.

Many GLP-1 telehealth platforms separate care access from medication. The advertised "$39/month" or "$25 first month" gets you membership; the medication is billed separately, often through a partner pharmacy at cash-pay rates. This isn't necessarily hidden — Hims, GoodRx Care, WeightWatchers, Sesame, Walgreens, Lemonaid, Noom Med (branded path), and Amazon One Medical all disclose it on their pricing pages. But it is the single biggest reason people end up paying multiples of what they thought.

The right question: Not "what's the membership fee?" but "what's the cash-pay maintenance-dose price for the medication path I'll actually be on?"

2. Mandatory Membership Stacked on Top of Medication

18 of 30 providers charge a recurring membership fee.

The reverse pattern: providers that advertise a lower compounded medication price but require a separate care or platform fee. Mochi Health is the clearest example: compounded semaglutide at $99/month is accurate, but the patient is also paying $79/month for the Mochi membership. The actual first-year math is ($79 + $99) × 12 = $2,136, not $99 × 12 = $1,188. Both numbers are honestly disclosed by Mochi; we're not calling this hidden. We are pointing out that the headline number is less than half of the year-one cost. Lemonaid Health follows a similar pattern: $49/mo membership + $199–$299/mo medication.

3. Dose-Escalation Upcharges

Some providers price the medication by dose, so what you pay at the starter dose is materially less than what you pay at the maintenance dose.

Wegovy injection (Novo NovoCare Pharmacy): $199/mo for first two fills at 0.25 mg and 0.5 mg only (offer through June 30, 2026), then $349/mo for 0.25/0.5/1/1.7/2.4 mg, and $399/mo for Wegovy HD 7.2 mg. Without savings offer: $499/mo.

Wegovy pill (Novo NovoCare Pharmacy): $149/mo for 1.5 mg and 4 mg (4 mg offer through Aug 31, 2026, then $199/mo); $299/mo for higher doses.

Zepbound (Eli Lilly self-pay): $299 for 2.5 mg; $399 for 5 mg; $449 for 7.5 mg, 10 mg, 12.5 mg, and 15 mg when refilled within 45 days.

Ozempic (Novo, type 2 diabetes): $199/mo intro then $349/mo for 0.25/0.5/1 mg doses; $499/mo for the 2 mg dose.

Foundayo (Eli Lilly, FDA-approved April 1, 2026): self-pay starts at $149/mo lowest dose, scaling to higher tiers; $25/mo with eligible commercial insurance; eligible Medicare Part D individuals may pay $50/mo beginning July 1, 2026.

Compounded programs: GobyMeds openly advertises dose-tiered 12-week plans. CoreAge RX and MyStart Health publicly claim flat-rate pricing — both flagged for checkout verification.

4. Lab Fees That Are State-Specific or Refill-Only

9 of 30 providers have lab handling that's separate, state-specific, or refill-only.

Sesame states labs are included in subscription except in some states where lab fees are additional. Walgreens states labs aren't required for the first visit or initial prescription but are required for refills. Join Fridays states all lab tests through Quest Diagnostics are fully included in the monthly subscription with no additional fees. Several programs let you upload outside labs taken within the past 12 months to skip new ones; if your PCP already pulled an HbA1c and comprehensive metabolic panel, that can save $100–$300.

5. Cancellation Friction, Commitments, and Refund Limits

7 of 30 providers have explicit annual or multi-month commitments visible in their public terms.
  • WeightWatchers Med+ requires a 12-month commitment for the $25/$74 pricing.
  • Henry Meds states on multi-month plans, the remaining balance is owed if cancelling early unless medically unable to continue; refunds limited to medically ineligible cases.
  • Found's published offer terms say subscription fees are final and non-refundable to the extent permitted by law.
  • MEDVi published terms reflect auto-renew with at-least-72-hours-before-next-billing cancellation window.
  • Sesame annual plan requires 12-month billing cadence to access $59/mo pricing; monthly is $99/mo.
This category isn't just a customer-experience issue — it's a regulatory issue. The FTC's July 2025 enforcement action against telemedicine firm NextMed alleged misleading prices, deceptive cost claims, undisclosed fees, long commitments, cancellation issues, and review manipulation; the final order required clearer cost disclosures and easier cancellation/refund practices. Read the terms. Save them.

Are GLP-1 Medications Included in Telehealth Memberships?

Sometimes, but often not. Across 30 providers in this audit, 22 advertise prices that don't include the medication at the maintenance dose. Three patterns matter, and there's a single best question to ask before you sign up.

Pattern 1 — Membership + medication separate (most common)

Hims, Hers, Ro Body, WeightWatchers Med+, GoodRx Care, Sesame, Walgreens, Lemonaid, Noom Med (branded path), Amazon One Medical. Recurring fee for clinician access + medication billed separately.

Pattern 2 — Bundled compounded (medication included)

GobyMeds, MyStart, MEDVi (mostly), Mochi (line-itemed alongside membership), CoreAge RX. The price covers the medication — no separate dispensing charge. Typically compounded-only or compounded-primary programs.

Pattern 3 — Hybrid

Eden, Henry Meds, Sesame's brand-name path, Noom Med's GLP-1 program path. One bundled price for compounded; separate cash-pay price for brand-name. Read the terms.

The single most useful question to ask a provider before you commit: "At the maintenance dose for the medication you'd prescribe me, what's the all-in monthly cost — membership plus medication plus labs plus shipping?" If they can't answer that in writing, that's information.

For more on insurance coverage and prior authorization, see our GLP-1 telehealth safety checklist.

Cheapest GLP-1 Telehealth Real Cost by Scenario (May 8, 2026)

All paths flagged for checkout verification before they can be promoted to verified. Phase 2 in progress.

Cheapest Cash-Pay Compounded Semaglutide

CoreAge RX publicly advertises compounded semaglutide from $99/month when paid annually with all doses at the same flat rate, no membership fee, no consultation charges, and LegitScript certification. Public-source year-one estimate: $99 × 12 = $1,188, pending checkout verification.

Join Fridays advertises sema from $117/mo with membership and Quest labs included — public-source estimate ~$1,404+ year-one. Mochi Health ($79 membership + $99 sema) lands at $2,136.

For more on compounded options, see our full GLP-1 telehealth comparison.

Cheapest Cash-Pay Compounded Tirzepatide

CoreAge RX publicly advertises tirzepatide from $149/month when paid annually, all doses same price. Public-source year-one estimate: $149 × 12 = $1,788, pending checkout verification.

Join Fridays advertises tirz as low as $198/mo with membership and labs included — year-one estimate ~$2,376+. Mochi Health at $79 + $199 = $278/mo lands at $3,336.

Cheapest Cash-Pay Brand-Name Path (Wegovy, Zepbound, Foundayo)

Brand-name first-year cash cost is going to be at least $3,000–$5,500 even with manufacturer savings programs.

ProviderPathEst. year-one (cash, with manufacturer offer)
Amazon One MedicalNo required membership + Wegovy injection at $299/mo Amazon Pharmacy cash-pay~$3,588+
Walgreens$49/visit (cadence varies) + Wegovy injection via Novo offer~$3,888 medication + visit cost
GoodRx Care$39/mo care + Wegovy injection via Novo offer ($199 first 2 fills, then $349)~$4,356
Sesame (annual plan)$59/mo + Wegovy injection via Novo offer~$4,596

For Foundayo (oral pill): LillyDirect self-pay starts at $149/mo lowest dose. Eligible commercially insured patients may pay as little as $25/mo via manufacturer savings card.

Cheapest with Insurance That Covers GLP-1

Form Health focuses on insurance-billed brand-name programs. WeightWatchers Med+ also handles insurance assistance. Mochi Health publishes that with in-network insurance, members can access services with $0 copay/deductible plus a 26% discount on membership. Amazon One Medical lists Foundayo at $25/mo with eligible commercial insurance via the manufacturer savings card. Insurance pricing depends on your specific plan — pull your formulary, check whether GLP-1 weight-loss medications are covered (separate from diabetes coverage), and whether prior authorization is required.

Provider-by-Provider Audit Notes (Alphabetical)

Notes are alphabetical so the section doesn't read as a ranking; the table above is the comparison. Each note ends with a "last verified" date and a verification flag.

Amazon One Medical

Public-source

No required One Medical membership to start GLP-1 Management Program; medication via Amazon Pharmacy at published cash-pay rates. Wegovy injection cash-pay starts at $299/mo; Wegovy pill $149/mo; Zepbound auto-injector and KwikPen starts at $299/mo; Foundayo $149/mo or $25/mo with eligible commercial insurance. No automatic membership add.

Last verified: May 8, 2026

Calibrate

Public-source

Insurance-favored model with program fee structure dependent on coverage. Refund limits, notice windows, and conditions in public terms. First-year cost NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

CoreAge RX

Public-source

Public claim: compounded sema $99/mo and tirz $149/mo when paid annually, all doses same price, no membership, LegitScript-certified, no cancellation fees. "Whatever price you lock in at checkout stays the same for all future months, regardless of dose increases." Year-one: sema $1,188, tirz $1,788. NEEDS CHECKOUT VERIFICATION of annual billing, state availability, pharmacy partner, refund/cancellation logistics.

Last verified: May 8, 2026

Eden

Public-source

Flat-rate compounded program with brand-name available at higher cost; $80-off first-month promo widely advertised. First-year math NEEDS CHECKOUT VERIFICATION for flat-rate maintenance and brand-name path.

Last verified: May 8, 2026

Fella Health

Public-source

Men-focused subscription program with compounded and brand-name paths. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Form Health

Public-source

Insurance-billed brand-name model. If your plan covers Wegovy or Zepbound, this is a viable path. NEEDS CHECKOUT VERIFICATION — heavily insurance-dependent.

Last verified: May 8, 2026

Found

Public-source

Multiple plan tiers: Monthly CORE $129/30 days; Quarterly CORE 2× $348 for 6-month commitment; 6-Month CORE $594. Subscription fees final / non-refundable to the extent permitted by law; cancel via app/portal, retain access through end of billing period. Year-one (Monthly CORE care fee only): $1,548 before medication. Medication path NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

FuturHealth

Public-source

Subscription program with compounded and brand options. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

GobyMeds

Public-source

Dose-tiered 12-week plans. Compounded sema: 12-week Starter Plan $299 ($93/mo with JUMPSTART promo through Dec 31, 2025); higher-dose 12-week from $399 (0.2–1.5 mg) or $499 (1.9–2.3 mg); 1-month any-dose $169. Compounded tirz: 3-month Starter Plan $399; higher-dose from $499 (1.5–9 mg) or $599 (11–13.5 mg). No membership; LegitScript-certified. Brand available at $1,399–$1,695/mo because GobyMeds doesn't bill insurance. Maintenance-dose year-one requires checkout verification and a stated dose-schedule assumption — flagged accordingly.

Last verified: May 8, 2026

GoodRx Care

Public-source

$39/mo online care + medication separate; brand-name Wegovy/Ozempic via Novo NovoCare Pharmacy cash-pay program. Year-one: $468 care + ~$3,888 Wegovy injection = ~$4,356 all-in.

Last verified: May 8, 2026

Henry Meds

Public-source

Monthly and multi-month compounded plans. Cancellation: via patient portal, support email, or phone. On multi-month plans, remaining balance owed if cancelling early unless medically unable to continue, as determined by a healthcare provider. Refunds limited to situations where patient is no longer medically eligible to continue therapy, less applicable fees. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Hims Weight Loss

Public-source

$39 first month, $149/mo thereafter. Active membership required; medication billed separately. Care fee year-one: $39 + $149×11 = $1,678 before medication. Product-specific medication pricing NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Hers Weight Loss

Public-source

Mirrors Hims structure: $39 first month, $149/mo membership thereafter; medication separate. Care fee year-one: ~$1,678 before medication. NEEDS PRODUCT-SPECIFIC CHECKOUT VERIFICATION.

Last verified: May 8, 2026

IVIM Health

Public-source

Compounded-focused subscription. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Join Fridays

Public-source

Subscription program where Quest lab tests are fully included with no additional fees per public claim. Current pricing: sema from $117/mo, tirz as low as $198/mo with membership included. Year-one: ~$1,404+ (sema), ~$2,376+ (tirz). NEEDS CHECKOUT VERIFICATION for promo codes, term length, and recurring billing.

Last verified: May 8, 2026

Lemonaid Health

Public-source

$49/mo membership + medication separate. Cash-pay only; does not accept insurance for weight-loss services or medication. HSA/FSA accepted. Compounded sema: $299/mo monthly, $249/mo on 3-month plan. Compounded tirz: $299/mo monthly, $249/mo on 3-month, $229/mo on 6-month. Microdose paths: $199/mo monthly. Brand: Ozempic $1,199/mo, Wegovy $1,599/mo. Year-one: microdose path $2,976; standard compounded monthly $4,176.

Last verified: May 8, 2026

LifeMD

Public-source

Subscription model with brand-name and compounded paths. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

MEDVi

Public-source

Low-entry compounded pricing with auto-renewal and 72-hour cancellation window. Sema: $179 first month, $299/mo refills. Tirz: $349/mo. Oral GLP-1 tablets: $249/mo. Year-one: sema $3,468; tirz $4,188. ⚠ February 20, 2026 FDA warning letter #721455 cited misbranding for claiming "Same active ingredient as Wegovy®" and "Same active ingredient as Mounjaro®." MEDVi named in pending litigation; allegations are not proven findings.

Last verified: May 8, 2026

Mochi Health

Public-source

$79/mo membership + compounded sema $99/mo or compounded tirz $199/mo. Insurance integration: $0 copay/deductible on covered plans + 26% membership discount per public claim. Year-one (cash): sema path $2,136; tirz path $3,336.

Last verified: May 8, 2026

MyStart Health

Public-source

$149/mo on the 3-month compounded sema plan with a price-lock guarantee per public claim. Different prices on different landing pages ($179, $297, $299) — $149/mo is specifically the 3-month plan. Year-one: $149×12 = $1,788. NEEDS CHECKOUT VERIFICATION of price-lock at maintenance dose.

Last verified: May 8, 2026

Noom Med — branded path

Public-source

Branded-medication path: $69 first month + $99/mo thereafter, medication billed separately. Care fee year-one: $1,158 before medication.

Last verified: May 8, 2026

Noom Med — GLP-1 program path

Public-source

Multiple bundled plan tiers per public pricing page. Should not be collapsed with the branded path. NEEDS CHECKOUT VERIFICATION — multiple plan tiers.

Last verified: May 8, 2026

OnlineSemaglutide.org / CareGLP

Third-party verified

Competitive headline pricing with no membership advertised, but a $80 telehealth consultation fee surfaces in checkout fine print if no order proceeds — documented by Policy Lab during third-party checkout testing. LegitScript-certified per public claim. NEEDS CHECKOUT VERIFICATION for full first-year math; the fee disclosure issue is the headline.

Last verified: May 8, 2026

OrderlyMeds

Public-source

Compounded-focused, monthly cadence, no membership advertised. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

PlushCare

Public-source

General telehealth membership + per-visit fees, with medication separate. Brand-name primarily; works with insurance. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

ReflexMD

Public-source

Compounded sema and compounded tirz, monthly cadence. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Ro Body

Public-source

Membership-required model with $39 first-month discount and monthly or annual membership options. Medication not included; at-home lab collection may cost extra. Care fee year-one (monthly path): ~$1,678 before medication. Care + medication path varies materially. NEEDS CHECKOUT VERIFICATION for medication path math.

Last verified: May 8, 2026

Sesame (Success by Sesame)

Public-source

$99/mo month-to-month or $59/mo on annual plan; medication separate. Labs included in subscription except in some states where additional. Brand-name Wegovy partnership uses Novo NovoCare Pharmacy cash-pay program. Care fee year-one (annual plan): $708 before medication. Annual plan + Wegovy injection at maintenance: ~$4,596 all-in.

Last verified: May 8, 2026

ShedRx (SHED)

Public-source

Subscription with compounded and brand options. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Walgreens Weight Management

Public-source

No subscription required; per-visit model. $49 initial video visit; $49 follow-ups when required. Labs not required for first visit; required for refills. Medication at Novo/Lilly published cash-pay rates. Year-one depends on visit cadence — we do not annualize $49/visit to $588 unless cadence is verified.

Last verified: May 8, 2026

WeightWatchers Clinic / Med+

Public-source

$25 first month with 12-month commitment, then $74/mo; medication not included. Care fee year-one: $839 before medication. Year-one (Wegovy injection at maintenance via cash-pay): ~$4,727 all-in.

Last verified: May 8, 2026

Zealthy

Public-source

Per-month subscription with compounded paths. NEEDS CHECKOUT VERIFICATION.

Last verified: May 8, 2026

Ready to compare providers on your specific medication path and budget? Use our best GLP-1 telehealth providers comparison →

How to Verify the True Cost Yourself Before You Sign Up

If you don't trust our audit (and you shouldn't fully trust any single source on a topic with this much money on the line), here's the protocol we use. About 20 minutes per provider.

1

Capture the advertised price + qualifier.

Open the homepage and the pricing page. Screenshot the headline number and read the asterisks. Is this a first-month price, a starter-dose price, a membership-only price, or an all-in price?

2

Complete the intake to checkout — but don't pay.

Sign up with a real email (or a forwarder), answer the medical questions truthfully, and proceed until the page right before payment. Do not provide insurance you don't intend to use. Do not misrepresent your medical history to obtain a prescription.

3

Screenshot every fee at every step.

Subscription. Medication at the dose proposed. Lab. Shipping. Initial consult. Anything else.

4

Ask support, in writing, about the four cost drivers.

(a) "Are labs included or billed separately?" (b) "Does the price increase at higher doses?" (c) "Can I cancel month-to-month, and what's your refund policy?" (d) "What is my all-in monthly cost at the maintenance dose?" Save the responses.

5

Compare the pricing page to the checkout page.

The pricing page is marketing; the checkout is the contract.

6

Calculate maintenance-month cost.

Take the maintenance-dose monthly figure (membership + medication + labs amortized + shipping) and write it down.

7

Calculate first-year total.

Using our formula: titration months at titration pricing + maintenance months × maintenance pricing + labs + visits + commitment math.

What This Audit Does Not Tell You

This is a price-transparency audit. It is not medical advice. It is not a clinical-quality ranking. It is not a recommendation about whether you should be on a GLP-1, which medication is right for you, or which provider is clinically best.

  • Clinical quality and safety beyond regulatory baseline. We record whether the provider publicly names a pharmacy partner and whether that pharmacy can be independently verified. We don't rank clinician quality.
  • Insurance-billed costs in detail. Coverage, prior authorization, deductibles, copays, and formulary placement vary by plan; we report cash-pay first-year cost as the standardized number.
  • State-specific availability. Some providers don't operate in all 50 states.
  • Live pricing. This is point-in-time. Promotional offers expire. Manufacturer cash-pay programs change. The "last verified" date on each row is the contract.
  • Long-term outcomes. First-year cost ≠ long-term value.
  • Whether compounded GLP-1 is appropriate for you. Discuss with a licensed clinician.

A Note on Compounded GLP-1 in 2026

Compounded GLP-1 in this audit means a non-FDA-approved compounded drug product dispensed by a state-licensed pharmacy or produced by an outsourcing facility when applicable legal conditions are met. It is not a generic version of Wegovy, Ozempic, Zepbound, Mounjaro, or Foundayo, and the FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.

The 2026 regulatory posture is materially stricter than the 2024 posture. The FDA determined the tirzepatide injection shortage was resolved on December 19, 2024, and the semaglutide injection shortage was resolved on February 21, 2025, ending the broad enforcement-discretion windows that previously enabled mass-market compounding. On April 1, 2026, the FDA stated that combining semaglutide with another active ingredient like vitamin B12 may still be "essentially a copy" of an approved drug unless a prescriber documents a patient-specific significant difference. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. In March 2026, the FDA issued warning letters to 30+ telehealth companies for misleading marketing of compounded GLP-1 products.

For a deeper look at safety and regulatory framing, see our GLP-1 side effects and safety guide.

What Screenshots Can and Cannot Prove

Screenshots can prove:

  • The price displayed on a date
  • The membership requirement displayed
  • Whether medication was shown as included or excluded
  • The lab-fee disclosure
  • The dose price disclosure
  • The cancellation/refund terms language as published
  • The checkout total before payment

Screenshots cannot prove:

  • Future pricing
  • Provider medical quality
  • Every state's availability
  • Insurance approval for a specific patient
  • Whether a clinician will prescribe to a specific patient
  • Whether a patient should use a medication

How and When We Update This Audit

Full re-auditAnnually (next: 2027 audit)
Spot-checks on top providersQuarterly
Manufacturer cash-pay program changesMonthly check
FDA actionsMonitored monthly; updated within 24–48 hours of major action
FTC/state enforcementMonitored monthly

Public changelog

v1.0 — May 8, 2026: Initial publication. 30 providers compiled from public pricing pages. Standardized fee schema applied. Phase 2 checkout-verification rollout begins with top 10 providers by traffic.

If a provider believes a price, term, or screenshot is outdated or incorrect, send the current public URL, the corrected term, and the effective date to [email protected]. We review, update if verified, and preserve the prior version in this changelog.

For Journalists and Researchers (Press Kit)

Free to use with attribution.

Headline Findings (Suggested for Citation — Phase 1, May 8, 2026)

  • Across 30 GLP-1 telehealth providers compared on identical fee schema as of May 8, 2026, 22 advertised prices that did not include the medication at the maintenance dose.
  • 18 of 30 providers in the audit charge a recurring membership or care-access fee on top of medication.
  • 11 of 30 providers use first-month, starter-dose, or limited-time pricing in their primary headline number.
  • 9 of 30 providers have lab handling that is separate, state-specific, or refill-only.
  • 7 of 30 providers have explicit annual or multi-month commitments visible in their public terms.
  • The cheapest Phase 1 public-source starting price is from CoreAge RX, which advertises compounded semaglutide from $99/month and compounded tirzepatide from $149/month, all doses same price, no membership fee, when paid annually.
  • The advertised-to-first-year gap is calculated per row in the table and will be reported as min/median/max after Phase 2 checkout verification completes.

Suggested Citation Format

Weight Loss Provider Guide. (2026). 2026 GLP-1 Telehealth True First-Year Cost Audit. https://weightlossproviderguide.com/research/glp1-telehealth-true-cost-audit/ — Last verified May 8, 2026, data version v1.0 (Phase 1 — Public-Source Pricing Audit).

Copy-Paste Citation Sentence

"According to Weight Loss Provider Guide's 2026 GLP-1 Telehealth True First-Year Cost Audit, which compared 30 GLP-1 telehealth providers on a standardized fee schema as of May 8, 2026, the advertised first-month price often differed from the verified first-year cash cost once membership, medication at maintenance dose, labs, dose increases, and cancellation terms were included."

Downloads

  • Download the dataset (CSV) — every row, every cell, last-verified date, source URL
  • XLSX download — with formulas exposed in a separate tab (coming Phase 2)
  • JSON download — for programmatic use (coming Phase 2)
  • Methodology PDF — full formula, fee classification rules, checkout protocol (coming Phase 2)

License & Contact

Dataset published under CC BY 4.0. Use it, embed it, republish charts, build on it. Attribution required.

Research contact: [email protected] — typical response within two business days.

Want to verify our work? Pick any provider in the audit, open the source URL listed, and re-run the checkout using a Privacy.com card.

Embeddable Interactive — GLP-1 Telehealth First-Year Cost Calculator

Select provider, medication path, state, billing cadence, dose path, and lab path; the calculator returns the public-source or checkout-verified first-year cost with itemized fees and links to the source/screenshot evidence. The calculator pulls from the same dataset as this audit. Embed snippet available on request at [email protected].

Frequently Asked Questions

The true cost of GLP-1 telehealth is the total required first-year cash cost at the maintenance dose, including membership or care-access fees, medication, required labs, required visits, shipping, and unavoidable commitment or cancellation costs. It is not the first-month promo price or the starter-dose price.

Often not. Of the 30 providers in this audit as of May 8, 2026, 22 advertise prices that do not include the medication at the maintenance dose — the price covers care access or membership, with the medication billed separately. We mark "medication included" only when the tested price covers the medication.

The advertised price often describes the first month, the starter dose, the care membership alone, or the medication alone. The checkout typically adds membership, labs, visits, dose-tiered medication pricing, or shipping. None of these are necessarily hidden — but they are easy to miss.

It depends on the provider, the state, and whether you are on the first prescription or a refill. Some include labs (Join Fridays explicitly does for Quest tests), some bill separately, and some are state-specific (Sesame includes labs except in some states where lab fees are additional).

Brand-name programs almost always do — both Novo's Wegovy and Ozempic cash-pay structures and Lilly's Zepbound and Foundayo cash-pay structures are dose-tiered. Some compounded programs publicly claim flat-rate pricing across doses (CoreAge RX, MyStart Health price-lock claim); others advertise dose-tiered 12-week plans (GobyMeds). The audit marks each row.

No. Compounded drugs are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Compounded GLP-1 may be permitted under specific conditions in sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act, but FDA enforcement tightened materially in 2026, including warning letters to 30+ telehealth companies in March 2026 and a proposal on April 30, 2026 to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list.

Usually, but terms vary. Some are month-to-month with online cancellation. Others have annual or multi-month commitments, notice windows, non-refundable subscription fees, or require a phone call to cancel. The FTC took enforcement action in this space (NextMed, July 2025), so cancellation language is increasingly important. Read the terms and save them before signing up.

First-year cost captures starter-month discounts, dose-escalation increases, lab requirements, membership commitments, and refill or follow-up costs that a single monthly headline price can hide. A "$99/month" starter-dose price for a medication that costs $349/month at the maintenance dose is a $2,400+ first-year difference.

The full audit is refreshed annually, with quarterly spot-checks on top providers and immediate updates when major provider pricing, FDA guidance, or FTC enforcement actions change. Manufacturer cash-pay programs are checked monthly. The "last verified" date on each row is the contract.

Yes. Use the suggested citation format in the press kit section, include the version date (v1.0, May 8, 2026), and cite the dataset rather than treating any single number as live pricing. The dataset is published under CC BY 4.0.

No. This is a pricing and transparency audit, not medical advice and not a recommendation to use or avoid any specific medication or provider. Consult a licensed clinician about which medication and program is appropriate for your health history.

Send the provider name, the URL of the page or checkout step that was captured, the corrected term, the effective date, and any supporting screenshot to [email protected]. We review, update if verified, and log the change in the public changelog with prior version preserved.

About This Audit

Built by: the Weight Loss Provider Guide research team. No fabricated reviewers, credentials, or "medically reviewed by" claims. Where clinical statements appear (such as maintenance-dose ranges for semaglutide and tirzepatide), we cite published prescribing information and labeling. Where regulatory statements appear, we cite FDA and FTC primary sources directly.

Editorial standards: We follow E-E-A-T principles for YMYL content. We do not treat compounded GLP-1 products as generic versions of FDA-approved drugs, and we do not repeat provider claims that imply FDA approval, sameness, or equivalent safety/effectiveness unless the claim is being documented as a claim made by the provider.

Last full review: . Data version: v1.0. Audit phase: Phase 1 — Public-Source Pricing Audit (checkout-verified rows added per provider as Phase 2 rolls out). The page URL doesn't change as Phase 2 completes.

Affiliate disclosure (full): Weight Loss Provider Guide has paid affiliate relationships with several providers listed in this audit, including Eden, MEDVi, Ro, ShedRx, and others. Affiliate payouts do not control this audit's findings, ordering, or scoring. If a high-payout affiliate scores poorly on cost transparency, that's what we publish.